ABEONA THERAPEUTICS INC. 10-Q filing
Filed 2026-05-13 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001493152-26-022614
- Form type
- 10-Q
- CIK
- 0000318306
- Primary document
- https://www.sec.gov/Archives/edgar/data/318306/000149315226022614/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ABEONA THERAPEUTICS INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $8.7M | - | - |
| Cost Of Revenue | $2.7M | - | - |
| Operating Income | $-23.0M | - | - |
| Net Income | $-17.1M | - | - |
| Eps Basic | -0.3 | - | - |
| Eps Diluted | -0.3 | - | - |
| Cash And Equivalents | $61.4M | - | - |
| Total Assets | $198.5M | - | - |
| Total Liabilities | $53.6M | - | - |
| Shareholders Equity | $144.9M | - | - |
| Operating Cash Flow | $-19.8M | - | - |
| Capital Expenditures | $935,000 | - | - |